<DOC>
	<DOCNO>NCT01172925</DOCNO>
	<brief_summary>The feeling shortness breath common lung cancer . It uncomfortable patient upset family . Although drug like morphine oxygen help patient feel well , n't help everybody , use patient early symptom . More relief need patient . The investigator study drug call tiotropium , use emphysema . It inhaler open airway allow easy breathing . Every patient get drug also placebo , random ( flip coin ) order . They get 2 week . The investigator see feel good drug .</brief_summary>
	<brief_title>Study Tiotropium Inhaler For Shortness Breath Advanced Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>1 . Histologically cytologically proven incurable stage IIIb stage IV nonsmall cell lung cancer . 2 . Dyspnea define score 2 high 10point Dyspnea Numeric Scale ( Appendix 2 ) . 3 . New dyspnea worsen dyspnea within last 6 month per patient reporting . 1 . Age &lt; 18 . 2 . An FEV1 / FVC ratio &lt; 0.7 FEV1 &lt; 80 % predict postbronchodilator . 3 . Life expectancy &lt; 3 month . 4 . Significant worsen dyspnea last week acute cardiac respiratory condition consider likely ( e.g . pneumonia , heart failure ) . 5 . Myocardial infarction within previous month . 6 . Heart rate ≥ 120 . 7 . Active tuberculosis tuberculosis receive antibiotic therapy . 8 . Current previous use ipratropium , tiotropium , oxitropium ( see Appendix 6 ) . 9 . Sensitivity atropine . 10 . Preexisting diagnosis asthma moderate severe Chronic Obstructive Pulmonary Disease 11 . Use betaadrenergic bronchodilator per week . 12 . Use experimental therapy know cholinergic adrenergic effect . 13 . Uncontrolled glaucoma . 14 . Urinary retention . 15 . An active upper low respiratory infection take antibiotic recent respiratory infection within 4 week . 16 . Symptomatic pleural pericardial effusion . 17 . Evidence reversible proximal endobronchial obstruction . 18 . Oxygen saturation &lt; 90 % . 19 . A hemoglobin &lt; 100 g/litre . Testing within 4 week randomization . 20 . Calculated urine creatinine clearance ≤ 50 mL/min ( see Appendix 5 calculation ) . Testing within 4 week randomization . 21 . Weight loss &gt; 10 % usual body weight within 6 month . 22 . Known pregnancy lactate . 23 . Unable independently fill quality life form give informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>dyspnea</keyword>
	<keyword>phase II</keyword>
	<keyword>crossover</keyword>
	<keyword>tiotropium</keyword>
</DOC>